Medicenna Therapeutics Corp. (TSX:MDNA)
Canada · Delayed Price · Currency is CAD 0.9700
+0.0500 (5.43%)
Jan 22, 2026, 4:00 PM EST
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of CAD 76.75 million as of January 22, 2026. Its market cap has decreased by -34.59% in one year.
Market Cap
76.75M
Enterprise Value
61.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.97
Market Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has increased from 65.63M to 76.75M, an increase of 16.94%. That is a compound annual growth rate of 1.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 76.75M | - |
| Dec 31, 2025 | 76.75M | -40.53% |
| Dec 31, 2024 | 129.06M | 341.25% |
| Dec 29, 2023 | 29.25M | -34.38% |
| Dec 30, 2022 | 44.57M | -60.68% |
| Dec 31, 2021 | 113.36M | -62.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 174.38M |
| Helix BioPharma | 165.74M |
| ME Therapeutics Holdings | 90.15M |
| Sharp Therapeutics | 72.18M |
| NurExone Biologic | 58.94M |
| Sernova Biotherapeutics | 52.19M |
| MedMira | 49.12M |
| BriaCell Therapeutics | 43.07M |